Quinidine Gluconate
1 NDC across 1 manufacturer|1 Generic,0 Brand
Quinidine Gluconate is used to treat atrial fibrillation and atrial flutter, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1 million on Quinidine Gluconate across 1,933 claims for 489 beneficiaries.
Quinidine Gluconate is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $4.92 to $4.92 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$4.92 – $4.92
per EA
7d Activity
avg -3.3% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sun Pharmaceutical Industries Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antiarrhythmic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing QUINIDINE GLUCONATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
QUINIDINE GLUC ER 324 MG TAB | $4.9220 per EA | -3.27% |
Frequently Asked Questions
What is Quinidine Gluconate used to treat?
Quinidine Gluconate is used to treat atrial fibrillation and atrial flutter, per the National Library of Medicine's MED-RT classification.
When did Quinidine Gluconate become available as a generic?
FDA approved the first generic Quinidine Gluconate (ANDA) on Jan 1, 1982. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Quinidine Gluconate?
In 2024, Medicare Part D spent $1 million on Quinidine Gluconate across 1,933 claims for 489 beneficiaries.
How many Quinidine Gluconate products are on the market?
The Quinidine Gluconate drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Quinidine Gluconate?
NADAC reference prices for Quinidine Gluconate range from $4.9220 to $4.9220 per EA.
Which manufacturers make Quinidine Gluconate?
1 manufacturer lists Quinidine Gluconate in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (1).
How has the price of Quinidine Gluconate changed recently?
Over the past 7 days, 0 Quinidine Gluconate NDCs rose and 2 fell, with a market-wide average change of -3.3%.